SLC25A30

Across TCGA pan-cancer cohorts, SLC25A30 mass-spec protein is linked to patient survival in 3 of 34 cancer types, making it a survival-associated SLC25A30 data layer compared with 25 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher SLC25A30 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated SLC25A30 expression acts as an unfavorable survival marker, although some lineages such as LSCC and LUAD show a favorable association.

LSCC, CCRCC, and LUAD are the cancer types where SLC25A30 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	OS	Median	All	0.956	0.809	.010	9	view →
CCRCC	DFS	Tertile	III,IV	0.047	1.000	.038	6	view →
LUAD	OS	Quartile	II,III,IV	1.000	0.520	.028	2	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

SLC25A30–LSCC (OS)

Open the LSCC breakdown →